Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Amniotic Fluid Ischemia Modified Albumin as a Novel e Prenatal Diagnostic Marker for Down Syndrome

NCT04293380 is registered in ClinicalTrials.gov with Karadeniz Technical University as lead sponsor.

NCT NCT04293380
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04293380 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Amniotic Fluid Ischemia Modified Albumin as a Novel e Prenatal Diagnostic Marker for Down Syndrome
Lead sponsor
Karadeniz Technical University
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2012
Completion date
September 1, 2016
Enrollment
94 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cytokines, down syndrome, prenatal stress